More on TELO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Telomir Pharmaceuticals (NQ:TELO)
Delayed: 1.03 +0.03 (3.00%)
Prev. Close $1.00  
Open$1.03 
52 Wk High$ 
52 Wk Low$ 
Day High$1.07 
Day Low$1.01 
P/E N/A  
EPS$ 
Volume40,420 

Friends, Peers and Foes (?): TDSGF, CBWTF, CCDS, CCDSF, CGRW (more...)

Oct 6, 2026 08:06 AM Telomir raises $5.6M in PIPE financing with DeJoria adding $1M
Oct 6, 2026 08:00 AM Form 8-K Telomir Pharmaceuticals, For: Oct 05
Oct 6, 2026 08:00 AM Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
Sep 29, 2026 03:31 AM Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing
Sep 17, 2026 08:32 AM Telomir-Zn shows retinal benefits in preclinical AMD study
Sep 17, 2026 08:31 AM Form 8-K Telomir Pharmaceuticals, For: Sep 17
Sep 17, 2026 08:30 AM Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
Sep 17, 2026 07:46 AM Maxim Group Starts Telomir Pharma (TELO) at Buy
Sep 16, 2026 04:31 PM Form 8-K Telomir Pharmaceuticals, For: Sep 11
Sep 15, 2026 06:32 AM Telo Genomics reports blood-based myeloma test outdetects bone marrow method
View All Articles

Entities mentioned with TELO

View All Entities